Marchini S - Search Results

1

Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743.

Marchini S, Marrazzo E, Bonomi R, Chiorino G, Zaffaroni M, Weissbach L, Hornicek FJ, Broggini M, Faircloth GT, D'Incalci M. Marchini S, et al. Eur J Cancer. 2005 Jan;41(2):323-33. doi: 10.1016/j.ejca.2004.10.021. Eur J Cancer. 2005. PMID: 15661559

2

Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.

Marchini S, Gonzalez Paz O, Ripamonti M, Geroni C, Bargiotti A, Caruso M, Todeschi S, D'Incalci M, Broggini M. Marchini S, et al. Anticancer Drug Des. 1995 Dec;10(8):641-53. Anticancer Drug Des. 1995. PMID: 8595123

3

Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.

Marchini S, Codegoni AM, Bonazzi C, Chiari S, Broggini M. Marchini S, et al. Br J Cancer. 1997;76(2):146-9. doi: 10.1038/bjc.1997.355. Br J Cancer. 1997. PMID: 9231912 Free PMC article.

4

Sequence-specific DNA alkylation of novel tallimustine derivatives.

Marchini S, Cozzi P, Beria I, Geroni C, Capolongo L, D'Incalci M, Broggini M. Marchini S, et al. Anticancer Drug Des. 1998 Apr;13(3):193-205. Anticancer Drug Des. 1998. PMID: 9595033

5

Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.

Marchini S, Cirò M, Gallinari F, Geroni C, Cozzi P, D'Incalci M, Broggini M. Marchini S, et al. Br J Cancer. 1999 Jun;80(7):991-7. doi: 10.1038/sj.bjc.6690453. Br J Cancer. 1999. PMID: 10362106 Free PMC article.

6

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.

Colella G, Marchini S, D'Incalci M, Brown R, Broggini M. Colella G, et al. Among authors: marchini s. Br J Cancer. 1999 May;80(3-4):338-43. doi: 10.1038/sj.bjc.6690360. Br J Cancer. 1999. PMID: 10408835 Free PMC article.

7

Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.

Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F. Fullwood P, et al. Among authors: marchini s. Cancer Res. 1999 Sep 15;59(18):4662-7. Cancer Res. 1999. PMID: 10493522

8

Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.

Minuzzo M, Marchini S, Broggini M, Faircloth G, D'Incalci M, Mantovani R. Minuzzo M, et al. Among authors: marchini s. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6780-4. doi: 10.1073/pnas.97.12.6780. Proc Natl Acad Sci U S A. 2000. PMID: 10841573 Free PMC article.

9

P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

Vikhanskaya F, Marchini S, Marabese M, Galliera E, Broggini M. Vikhanskaya F, et al. Among authors: marchini s. Cancer Res. 2001 Feb 1;61(3):935-8. Cancer Res. 2001. PMID: 11221886

10

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.

Marchini S, Damia G, Broggini M, Pennella G, Ripamonti M, Marsiglio A, Geroni C. Marchini S, et al. Cancer Res. 2001 Mar 1;61(5):1991-5. Cancer Res. 2001. PMID: 11280757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters